Victoria Grace
Founder @ Colle Capital Partners
New York, United States
Victoria Grace is a seed investor at Colle Capital Partners in New York focused on Software and SaaS. Victoria Grace is the Founding partner of Colle Capital Partners. She previously worked at Queen's Gambit Growth Capital as a Founder and CEO. Victoria Grace attended Washington University in St. Louis.
- Total investments:
- 22
- Last investment:
- Lead investor:
- 36%
Last updated:
For AI agents: llms.txt
Industries Victoria Grace invests in
Stages Victoria Grace invests in
Countries Victoria Grace invests in
Round sizes
Round size
- Seed
- $1.2M–$8M
- Series A
- $750k–$10M
Investment Focus
Industry
- Software 5 (23%)
- SaaS 3 (14%)
- Analytics 3 (14%)
- Health Care 3 (14%)
- Artificial Intelligence 3 (14%)
Stage
- Seed 11 (50%)
- Series A 6 (27%)
- Pre-Seed 1 (5%)
- Venture - Series Unknown 1 (5%)
Country
- United States 15 (68%)
- United Arab Emirates 2 (9%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Neuron Factory
|
Neuron Factory is an AI technology company specializing in the development of advanced AI coworker platforms designed for complex enterprise environments, with an initial focus on the construction industry. The company’s platform leverages a proprietary enterprise task graph, enabling AI agents to intelligently coordinate, delegate tasks, andfacilitate real-time decision-making across large organizations. | Seed / Mar 31, 2026 | |
|
Neuron Factory
|
Neuron Factory is an AI technology company specializing in the development of advanced AI coworker platforms designed for complex enterprise environments, with an initial focus on the construction industry. The company’s platform leverages a proprietary enterprise task graph, enabling AI agents to intelligently coordinate, delegate tasks, andfacilitate real-time decision-making across large organizations. | $6M / Seed / May 27, 2025 | |
Sensydia
|
Developer of a portable, point-of-care hemodynamic measurement platform that uses proprietary sensor technology and machine learning to guide critical patient management decisions in heart failure, sepsis, pulmonary hypertension, and other critical diseases. The Sensydia Cardiac Performance System™ (CPS) is entirely non-invasive, trained to goldstandard, and can be deployed in minutes in the hospital, clinic, office or at home. By making hemodynamic insights as accessible as routine blood pressure readings, CPS will enable early disease detection and improve disease management through accurate, easy-to-use, non-invasive monitoring. | $8M / Venture - Series Unknown / May 09, 2023 | |
Qureos
|
Qureos is a UAE-based AI recruitment and career-matching platform that helps employers automate candidate sourcing, screening, and hiring while providing job seekers with personalized job matching, resume feedback, and career support tools. Founded in 2021, the company operates across the GCC and MENA regions and has expanded into internationalmarkets. Its platform combines recruitment automation, AI-driven candidate matching, and talent management features through its AI recruiter assistant, Iris, which streamlines hiring workflows for businesses and recruitment teams. | $3M / Pre-Seed / Apr 06, 2022 | |
Haystacks.AI
|
Haystacks.AI uses real estate data, and numerous sources of ancillary data, to augment investment decisions in the single-family RE market. | $3M / Seed / Mar 22, 2022 | |
Dtek.AI
|
Dukkantek provides digital transformation services to improve business processes. It offers online solutions to assist with managing and marketing strategies of companies. Dukkantek is based in Dubai, UAE. | $5.2M / Seed / Mar 08, 2022 | |
Haystacks.AI
|
Haystacks.AI uses real estate data, and numerous sources of ancillary data, to augment investment decisions in the single-family RE market. | $8M / Seed / Dec 16, 2021 | |
|
Haystacks.AI
|
Haystacks.AI uses real estate data, and numerous sources of ancillary data, to augment investment decisions in the single-family RE market. | $8M / Seed / Dec 16, 2021 | |
Amulet
|
Allergy Amulet is the world’s smallest and fastest consumer food allergen sensor, testing for common allergenic ingredients in seconds. Whether it’s on a keychain, a necklace, a wristband, or in a pocket, Allergy Amulet’s sleek and portable design allows users to savor life’s important moments, safely and simply. Food allergies affect 32 millionAmericans and between 220-520 million people globally. That’s 1 in 13 children and 1 in 10 adults. Allergy Amulet has the potential to improve the quality of life for the millions of people living with food allergies or intolerances. | $4.1M / Seed / Aug 12, 2020 | |
Max-bone
|
max-bone is designed for your dog with you in mind. With uncomplicated and seasonless collections, max-bone’s mission is to provide your family with pieces that are both timeless and sophisticated. As the first branded pet label, max-bone follows culture, not trends, combining influences from fashion, art and architecture with upscale functionalityto deliver apparel, toys, beds, leashes and more that are effortlessly elegant. | Series A / Mar 05, 2019 | |
| See all 22 investments → | |||
Co-Investors
About Colle Capital Partners
Colle Capital is an opportunistic, global technology venture fund. We focus on early stage companies that offer products and services in a broad range of verticals, such as telecommunications, computing, compliance, healthcare, wireless, financial services, security, home automation and information technology.
Colle Capital Partners Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Doug Benowitz
Principal
|
|||
Kevin Lynch
Fund Administrator
|
|||
|
Victoria Grace
Founder
|
|||
2 more contacts available
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does Victoria Grace invest in?
Victoria Grace invests primarily in Software, SaaS and Analytics startups, most often at Seed and Series A stage. Most of the 22 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Victoria Grace's check size?
Victoria Grace typically joins rounds of $1.2M–$8M at Seed and $750k–$10M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Victoria Grace participates in.
When did Victoria Grace last invest?
The most recent investment recorded for Victoria Grace closed in Mar 2026. Shizune tracks 22 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
